Cardiol Therapeutics (CRDL) Retained Earnings (2020 - 2026)
Cardiol Therapeutics (CRDL) posted Retained Earnings of -$163.3 million for Q1 2026, down 6.85% on a QoQ basis from -$152.8 million in Q4 2025, and down 24.91% year-over-year from -$217.4 million in Q1 2025.
Cardiol Therapeutics (CRDL) Retained Earnings (2020 - 2026) Analysis & Trends
Cardiol Therapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$163.3 million for Q1 2026.
- Quarterly Retained Earnings fell 24.91% year-over-year to -$163.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$163.3 million (down 24.91% YoY) and the FY2025 annual result came in at -$152.8 million, down 19.07% from the prior year.
- Retained Earnings was -$163.3 million for Q1 2026 at Cardiol Therapeutics, down from -$152.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$73.0 million in Q1 2022 and bottomed at -$163.3 million in Q1 2026.
- A 5-year average of -$113.4 million and a median of -$112.6 million in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 41.66% — and 2025, when it declined 16.05%.
- Cardiol Therapeutics' Retained Earnings stood at -$84.3 million in 2022, then declined by 24.21% to -$104.7 million in 2023, then declined by 22.53% to -$128.3 million in 2024, then declined by 19.07% to -$152.8 million in 2025, then declined by 6.85% to -$163.3 million in 2026.
- Business Quant data shows CRDL's Retained Earnings at -$163.3 million in Q1 2026, -$152.8 million in Q4 2025, and -$149.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | -163.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163.26 Mn |
| Dec 31, 2025 | -152.79 Mn |
| Sep 30, 2025 | -149.62 Mn |
| Jun 30, 2025 | -141.38 Mn |
| Mar 31, 2025 | -130.70 Mn |
| Dec 31, 2024 | -128.32 Mn |
| Sep 30, 2024 | -125.86 Mn |
| Jun 30, 2024 | -115.77 Mn |
| Mar 31, 2024 | -112.62 Mn |
| Dec 31, 2023 | -104.73 Mn |
| Sep 30, 2023 | -100.66 Mn |
| Jun 30, 2023 | -96.04 Mn |
| Mar 31, 2023 | -89.90 Mn |
| Dec 31, 2022 | -84.31 Mn |
| Sep 30, 2022 | -81.99 Mn |
| Jun 30, 2022 | -77.62 Mn |
| Mar 31, 2022 | -73.00 Mn |
| Dec 31, 2021 | -66.26 Mn |
| Sep 30, 2021 | -61.38 Mn |
| Jun 30, 2021 | -54.79 Mn |